Evaluating Treatment and Rechallenge Challenges in Liver Injury Caused by Immune Checkpoint Inhibitors
Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapeutics, offering remarkable benefits across multiple malignancies, including hepatocellular carcinoma (HCC). However, their ...
